1. Nektar Therapeutics Strengthens Board of Directors with Appointment of Biotechnology Veteran

    Nektar Therapeutics Strengthens Board of Directors with Appointment of Biotechnology Veteran

    SAN FRANCISCO, /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced that it has appointed Karin Eastham as an independent ...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Topics Mentioned